"These results offer an explanation for the confusion that has occurred in this area since clinical trials of beta blockers began," Dorn says. "Our study demonstrates a mechanism that should lay to rest the question about whether beta blockers are effective in African-Americans they absolutely are in those who don't have this genetic variant."
'/>"/>
| Contact: Gwen Ericson ericsong@wustl.edu 314-286-0141 Washington University School of Medicine Source:Eurekalert |